Institutional investors purchased a net $7.5 million shares of IMMU during the quarter ended March 2016, and now own 39.86% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SIMPLEX TRADING LLC Bought 87.7 Thousand shares of Immunomedics Inc
CUTLER GROUP LP Bought 5.0 Thousand shares of Immunomedics Inc